Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR T790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery.

MLA

Yin, Weimin, et al. “Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR T790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery.” Small (Weinheim an Der Bergstrasse, Germany), vol. 14, no. 47, Nov. 2018, p. e1802372. EBSCOhost, https://doi.org/10.1002/smll.201802372.

APA

Yin, W., Yu, X., Kang, X., Zhao, Y., Zhao, P., Jin, H., Fu, X., Wan, Y., Peng, C., & Huang, Y. (2018). Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR T790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery. Small (Weinheim an Der Bergstrasse, Germany), 14(47), e1802372. https://doi.org/10.1002/smll.201802372

Chicago

Yin, Weimin, Xiaolu Yu, Xuejia Kang, Yuge Zhao, Pengfei Zhao, Hongyue Jin, Xuhong Fu, Yakun Wan, Chengyuan Peng, and Yongzhuo Huang. 2018. “Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR T790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery.” Small (Weinheim an Der Bergstrasse, Germany) 14 (47): e1802372. doi:10.1002/smll.201802372.